<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kremer, Joel M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">N-3 Fatty Acids at the Intersection of RA and CV Morbidity</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-28</style></pages><abstract><style  face="normal" font="default" size="100%">A meta-analysis of 17 randomized, controlled trials suggests that supplementation with oral n-3 fatty acids improves patient-assessed pain, duration of morning stiffness, and number of painful and/or tender joints in patients with rheumatoid arthritis [Bahadori B et al. JPEN J Parenter Enteral Nutr 2010; Kremer JM. Am J Clin Nutr 2007; Goldberg RJ, Katz J. Pain 2007].</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>